Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of AR116417A1publicationCriticalpatent/AR116417A1/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un método para el tratamiento del cáncer de mama mediante la administración de un inhibidor de TGFb en combinación con un inhibidor de CDK a un paciente que lo necesita.
ARP190102627A2018-09-182019-09-17COMBINACIONES DE INHIBIDORES DE TGFb E INHIBIDORES DE CDK PARA TRATAMIENTOS CONTRA EL CÁNCER
AR116417A1
(es)
métodos de tratamento de um indivíduo com câncer de mama, kit para o tratamento de câncer de mama e combinação de fármacos para terapia de câncer de mama